Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marko Babjuk

Showing results (61-70 of 119) with videos related to

Pageof 12
Sort By:
European Urology Focus|January 26, 2018
Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016"Eva M Compérat, Maximilian Burger, Paolo Gontero, et al.
Anticancer Research|May 1, 2007
The prognostic role of the STK15 T91A polymorphism and of STK15 mRNA expression in patients with urothelial cell carcinomaIman J Schultz, Lambertus A Kiemeney, Rian Roelofs, et al.
European Urology|August 22, 2006
Gene expression analysis for the prediction of recurrence in patients with primary Ta urothelial cell carcinomaIman J Schultz, Kenneth Wester, Huub Straatman, et al.
European Urology|July 20, 2015
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 UpdateMorgan Rouprêt, Marko Babjuk, Eva Compérat, et al.
International Journal of Cancer|May 25, 2006
Prediction of recurrence in Ta urothelial cell carcinoma by real-time quantitative PCR analysis: a microarray validation studyIman J Schultz, Kenneth Wester, Huub Straatman, et al.
European Urology|September 5, 2017
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 UpdateMorgan Rouprêt, Marko Babjuk, Eva Compérat, et al.
European Urology|February 2, 2010
Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendationsJ Alfred Witjes, Juan Palou Redorta, Didier Jacqmin, et al.
The Journal of Urology|December 17, 2013
Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancerTobias Klatte, Evanguelos Xylinas, Malte Rieken, et al.
European Urology Focus|February 26, 2018
Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical TrialPeter F A Mulders, Luis Martínez-Piñeiro, Axel Heidenreich, et al.
European Urology|August 29, 2012
Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancerMichael Rink, Helena Furberg, Emily C Zabor, et al.
Pageof 12

Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
European Urology Focus|January 26, 2018
Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016"Eva M Compérat, Maximilian Burger, Paolo Gontero, et al.
Anticancer Research|May 1, 2007
The prognostic role of the STK15 T91A polymorphism and of STK15 mRNA expression in patients with urothelial cell carcinomaIman J Schultz, Lambertus A Kiemeney, Rian Roelofs, et al.
European Urology|August 22, 2006
Gene expression analysis for the prediction of recurrence in patients with primary Ta urothelial cell carcinomaIman J Schultz, Kenneth Wester, Huub Straatman, et al.
European Urology|July 20, 2015
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 UpdateMorgan Rouprêt, Marko Babjuk, Eva Compérat, et al.
International Journal of Cancer|May 25, 2006
Prediction of recurrence in Ta urothelial cell carcinoma by real-time quantitative PCR analysis: a microarray validation studyIman J Schultz, Kenneth Wester, Huub Straatman, et al.
European Urology|September 5, 2017
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 UpdateMorgan Rouprêt, Marko Babjuk, Eva Compérat, et al.
European Urology|February 2, 2010
Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendationsJ Alfred Witjes, Juan Palou Redorta, Didier Jacqmin, et al.
The Journal of Urology|December 17, 2013
Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancerTobias Klatte, Evanguelos Xylinas, Malte Rieken, et al.
European Urology Focus|February 26, 2018
Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical TrialPeter F A Mulders, Luis Martínez-Piñeiro, Axel Heidenreich, et al.
European Urology|August 29, 2012
Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancerMichael Rink, Helena Furberg, Emily C Zabor, et al.
Pageof 12